Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-012878)

Filing Details

Accession Number:: 0001209191-22-012878
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-02-24 19:55:23
Reporting Period:: 2020-12-08

Accepted Time:: 2022-02-24 19:55:23
Original Submission Date:: 2020-12-08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671858	Silverback Therapeutics Inc.	SBTX	Pharmaceutical Preparations (2834)	811489190

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1831807	Russ Hawkinson	C/O Silverback Therapeutics, Inc. 500 Fairview Avenue N, Suite 600 Seattle WA 98109	Sr. Vice President Of Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-08	200	$21.00	200	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares were purchased in the Issuer's initial public offering.
On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock.